Join
Live feed
·
INSIDERFilingvia Quantisnow
Day One Biopharmaceuticals Inc. logo

Chief Commercial Officer Merendino Lauren converted options into 15,162 shares and sold $67,448 worth of shares (5,814 units at $11.60), increasing direct ownership by 18% to 60,157 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
DAWN· Day One Biopharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DAWN (Day One Biopharmaceuticals Inc.) and more on Quantisnow.